
CVS Health Corp (NYSE:CVS) stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance.
The company reported second-quarter sales of $98.90 billion on Thursday, beating the consensus of $94.85 billion.